Are Neon Therapeutics’ Shareholders Getting Enough in the Buyout?
Neon Therapeutics shares shot up on Thursday after the firm announced that it will be acquired by BioNTech. Are Neon Therapeutics shareholders getting enough out of the deal?
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 74
Why This Opioid Painkiller Is Killing Nektar Therapeutics Stock
Nektar Therapeutics shares were crushed on Wednesday after the FDA did not recommend the company’s pain drug.
Does FDA Decision Mean a Bright Future for This Flu Vaccine?
An FDA nod for NanoFlu, a recombinant quadrivalent seasonal influenza vaccine candidate, offered a boost to Novavax shares on Wednesday.
Does UnitedHealth Deserve More Credit for Q4?
When UnitedHealth reported mixed fourth-quarter financial results before the markets opened on Wednesday.
Growing Number of Americans Still Don’t Think Vaccines Are Important
Some Americans believe that vaccinations are more dangerous than the diseases they prevent. The number is growing, says Gallup.
Will UnitedHealth Lift the Dow Again When It Reports Wednesday?
UnitedHealth is scheduled to report its most recent quarterly results before the opening bell on Wednesday.
Why Aquestive Therapeutics’ Seizure Treatment May Get Butted Out
Aquestive Therapeutics' shares lost nearly a third on Monday after the firm received an update from the FDA concerning its seizure treatment.
This T-Cell Therapy Could Be a Game Changer for Adaptimmune
Adaptimmune shares absolutely exploded on Monday after the company announced encouraging responses for its Spear T-cell platform.
Short Sellers Shy Away From Big Pharma
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Major Biotechs Have Short Sellers Excited
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
20 Biopharma Stocks for Huge Upside Potential in 2020
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
How This Dermira Acquisition Will Round Out Eli Lilly
Dermira shares made a handy gain to close out the week after it was announced that Eli Lilly would be acquiring the firm.
How This Eye Study Is Making Waves
Applied Genetic Tech shares jumped by more than 50% on Thursday after the firm announced positive interim data from its midstage trial in X-linked retinitis pigmentosa.
Why This Peanut Allergy Study Was Worth the Wait
DBV Tech shares jumped on Thursday after the firm announced positive topline results from its late-stage study in children with a peanut allergy.
11 Biotech and Pharma Stocks With Huge Upside Targets for 2020
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.